Vertebral Osteomyelitis and Spondylodiscitis Are the Same Condition
Vertebral osteomyelitis and spondylodiscitis are synonymous terms referring to the same infectious process involving the vertebral bodies and intervertebral disc spaces. The term "spondylodiscitis" emphasizes the combined involvement of both the vertebral body (spondylitis) and the disc space (discitis), while "vertebral osteomyelitis" focuses on the bone infection component 1, 2, 3.
Pathophysiology
The infection typically results from hematogenous seeding of the adjacent disc space from a distant focus, as the disc is avascular 1. The infection spreads from the vertebral endplate to involve both the vertebral body and the adjacent disc space, creating the characteristic pattern seen on imaging. This explains why both terms describe the same disease process—the infection inherently involves both structures due to their anatomical proximity and vascular supply 4.
Key Pathophysiologic Features:
- Hematogenous spread is the most common route (from bacteremia, endocarditis, or distant infection sites) 5
- The rich vascular supply of the vertebral endplates allows bacterial seeding
- Infection spreads from endplate → vertebral body → disc space → adjacent vertebra
- Can extend to epidural space, paraspinal soft tissues, or form abscesses
Clinical Presentation
Both terms describe a condition with:
- Insidious onset of back or neck pain (most common presenting symptom) 1
- Fever (present in only 35-60% of cases—absence does not exclude diagnosis) 1
- Elevated inflammatory markers (ESR and CRP are typically elevated) 1
- Neurologic symptoms may occur with epidural extension or spinal instability 1
Suspect this diagnosis in any patient with new or worsening back/neck pain plus:
- Fever, OR
- Elevated ESR/CRP, OR
- Recent S. aureus bacteremia or endocarditis 1
Diagnosis
Imaging Approach:
MRI is the diagnostic modality of choice with highest sensitivity and specificity 1, 4. Plain radiographs are insensitive early in disease and should not be relied upon 1.
Microbiologic Diagnosis:
Obtain blood cultures first (positive in 40-70% of pyogenic cases) 1.
If blood cultures are negative and patient is not septic or neurologically compromised, withhold empiric antibiotics and perform CT-guided or surgical biopsy of the disc space or vertebral endplate for culture and pathology 1, 6.
Exception: If S. aureus bacteremia occurred within the preceding 3 months AND MRI shows compatible changes, biopsy is not required—proceed directly to treatment 1.
Management
Antimicrobial Therapy:
Treat for 6 weeks total duration based on the landmark randomized trial showing non-inferiority of 6 weeks versus 12 weeks 1.
Early switch to oral antibiotics is safe (after approximately 2-3 weeks IV) provided CRP is decreasing and any significant epidural/paravertebral abscesses have been drained 1, 6.
Antibiotic Selection (based on organism):
- S. aureus (most common): Use pathogen-directed therapy based on susceptibilities
- Gram-negative organisms: Fluoroquinolones (ciprofloxacin, levofloxacin) are preferred oral options 1
- MRSA: Linezolid 600 mg PO BID when first-line agents cannot be used 1
Surgical Indications:
Strongly recommend surgery for 1:
- Progressive neurologic deficits
- Progressive spinal deformity
- Spinal instability with or without pain despite adequate antibiotics
Consider surgery for 1:
- Persistent/recurrent bacteremia without alternative source
- Worsening pain despite appropriate medical therapy
- Large epidural abscess with mass effect
Do NOT operate solely based on worsening bony imaging at 4-6 weeks if clinical symptoms, exam, and inflammatory markers are improving 1.
Monitoring Treatment Response
Check ESR and CRP after approximately 4 weeks of treatment 1. Values >50 mm/hour (ESR) or >2.75 mg/dL (CRP) after 4 weeks may indicate higher risk of treatment failure 1.
Do NOT routinely obtain follow-up MRI in patients with favorable clinical and laboratory response 1. Radiographic findings often worsen or persist despite clinical improvement, leading to unnecessary interventions 1.
Only obtain follow-up MRI if:
- Poor clinical response to therapy (persistent/progressive pain, systemic symptoms)
- Elevated inflammatory markers after 4 weeks
- Focus on soft tissue changes (epidural/paraspinal), NOT bony changes 1
Common Pitfalls
- Starting empiric antibiotics before obtaining cultures in stable patients—this significantly reduces diagnostic yield 1, 6
- Relying on plain radiographs for early diagnosis—they are insensitive 1
- Treating longer than 6 weeks without specific indication—no benefit shown 1, 6
- Ordering follow-up MRI in clinically improving patients—bony changes lag behind clinical improvement and cause unnecessary alarm 1
- Operating based on radiographic progression alone when patient is clinically improving 1